Agilent Technologies Inc (NYSE:A)

70.70
Delayed Data
As of Feb 23
 +0.02 / +0.03%
Today’s Change
50.86
Today|||52-Week Range
75.00
+5.57%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$22.8B

Company Description

Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates through the following segments: Life Sciences & applied markets; Diagnostics & Genomics; and Agilent CrossLab Business. The Life Sciences & Applied Markets Business segment provides application-focused solutions that include instruments, software, consumables and services that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. The Diagnostics & Genomics Business segment is comprised of five areas of activity providing solutions that include reagents, instruments, software and consumables, which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab Business segment spans the entire lab with its consumables and services portfolio, which is designed to improve customer outcomes. The company was founded on May 1999 and is headquartered in Santa Clara, CA.

Contact Information

Agilent Technologies, Inc.
5301 Stevens Creek Boulevard
Santa Clara California 95051
P:(408) 345-8886
Investor Relations:
(408) 345-8948

Employees

Shareholders

Mutual fund holders46.68%
Other institutional41.51%
Individual stakeholders1.19%

Top Executives

Michael R. McMullenPresident, Chief Executive Officer & Director
Kristin GiffinVice President-Operations, Quality & Support
Didier HirschChief Financial Officer & Senior Vice President
Darlene J. S. SolomonChief Technology Officer & Senior Vice President
Nancy LelicoffVP-Regulatory Affairs & Clinical Affair